Original Communications| Volume 125, ISSUE 2, P155-159, February 1999

Download started.


Long-term outcome of a prospective trial of steroid withdrawal after kidney transplantation


      Background: Steroid withdrawal (SW) after kidney transplantation is desirable to avoid associated serious side effects. We studied the long-term outcome of a group of kidney transplant recipients who underwent SW. Methods: Between 1991 and 1993, kidney transplant recipients (N = 12) who had posttransplantation diabetes were entered in a prospective trial of SW. These patients were compared with a demographically similar comparison cohort (N = 66). End points of the study were patient and graft survival, incidence of late acute and chronic rejection, and changes in diabetes management. Results: Previously published data from the SW group at 15 months of follow-up indicated improvement in diabetes control without any adverse effect on patient or graft actuarial survival. At long-term follow-up (mean, 56 months) the improvement in diabetes management was not detectable. The incidence of late acute rejection in SW and cohort groups was 42% and 8%, respectively (P = .006). Likewise, the incidence of chronic rejection in the SW versus cohort group was 42% and 12%, respectively (P = .014). Conclusions: Although SW appeared to be successful initially, our long-term data indicate that SW significantly increases the risk of late acute rejection and chronic rejection episodes without benefits in posttransplantation diabetes management. Steroid withdrawal in patients with posttransplantation diabetes should be approached with caution. (Surgery 1999;125:155-9.)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Schulak JA
        • Hricik DE
        Steroid withdrawal after renal transplantation.
        Clin Transplant. 1994; 8: 211-216
        • Hricik DE
        • Lautman J
        • Moir EJ
        • Bartucci MR
        • Mayes JT
        • Schulak JA
        Variable effects of steroid withdrawal on blood pressure reduction in cyclosporine treated renal transplant recipients.
        Transplantation. 1992; 53: 1232-1235
        • Hricik DE
        • Bartucci MR
        • Moir EJ
        • Mayes JT
        • Schulak JA
        Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients.
        Transplantation. 1991; 51: 374-377
        • Pirsch JD
        • Armbrust MJ
        • Knechtle SJ
        • Reed A
        • D'Alessandro AM
        • Sollinger HW
        • et al.
        Effect of steroid withdrawal on hypertension and cholesterol levels in living related recipients.
        Transplant Proc. 1991; 23: 1363-1364
        • Kupin W
        • Venkat KK
        • Oh HK
        • Dienst S
        Complete replacement of methylprednisolone by azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
        Transplantation. 1988; 45: 53-55
        • Kjellstrant CM
        Side effects of steroids and their treatment.
        Transplant Proc. 1975; 7: 123-129
        • Friedman EA
        • Shyh TP
        • Beyer MM
        • Manis T
        • Butt KM
        Posttransplant diabetes in kidney transplant recipients.
        Am J Nephrol. 1985; 5: 196-202
        • Sumrani NB
        • Delaney V
        • Ding Z
        • Davis R
        • Daskalakis P
        • Friedman EA
        • et al.
        Diabetes mellitus after renal transplantation in the cyclosporine era: an analysis of risk factors.
        Transplantation. 1991; 51: 343-347
        • Ruiz JO
        • Simmons RL
        • Callender CO
        • Kjellstrand CM
        • Buselmeier TJ
        • Najarian JS
        Steroid diabetes in renal transplant recipients: pathogenic factors and prognosis.
        Surgery. 1973; 73: 759-765
        • Gunnarsson R
        • Lundgren G
        • Magnusson G
        • Ost L
        • Groth CG
        Steroid diabetes: a sign of overtreatment with steroids in the renal graft recipient?.
        Scand J Urol Nephrol Suppl. 1980; 54: 135-138
        • Hricik DE
        • Whalen CC
        • Lautman J
        • Bartucci MR
        • Moir EJ
        • Mayes JT
        • et al.
        Withdrawal of steroids after renal transplantation: clinical predictors of outcome.
        Transplantation. 1992; 52: 41-45
        • Hricik DE
        • O'Toole MA
        • Schulak JA
        • Herson J
        Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis.
        J Am Soc Nephrol. 1993; 4: 1300-1305
        • Fabrega AJ
        • Cohan J
        • Meslar P
        • Pollak R
        Effect of steroid withdrawal on long-term renal allograft recipients with posttransplantation diabetes mellitus.
        Surgery. 1994; 116: 792-797
        • Fabrega AJ
        • Meslar P
        • Cohan J
        • Lash J
        • Pollak R
        Long-term (24-month) follow-up of steroid withdrawal in renal allograft recipients with posttransplant diabetes mellitus.
        Transplantation. 1995; 60: 1612-1614
        • Benedetti E
        • Freels SA
        • Coady NT
        • Vasquez EM
        • Pollak R
        The impact of quadruple immunosuppression with OKT3 on kidney transplantation in black recipients.
        Am J Surg. 1996; 172: 56-60
        • Rosner B
        Fundamentals of biostatistics.
        4th ed. Duxbury Press, Boston1995
        • Collet D
        Modelling survival data in medical research.
        Chapman and Hall, London1994
        • Olefsky JM
        • Kimmerling G
        Effects of glucocorticoids on carbohydrate metabolism.
        Am J Med Sci. 1976; 271: 202-210
        • Mazariegos GV
        • Reyes J
        • Marino IR
        • Demetris AJ
        • Flynn B
        • Irish W
        • et al.
        Weaning of immunosuppression in liver transplant recipients.
        Transplantation. 1997; 63: 243-249
        • McDiarmid SV
        • Farmer DA
        • Goldstein LI
        • Martin P
        • Vargas J
        • Tipton JR
        • et al.
        A randomized prospective trial of steroid withdrawal after liver transplantation.
        Transplantation. 1995; 60: 1443-1450
        • Ratcliffe PJ
        • Dudley CR
        • Higgins RM
        • Firth JD
        • Smith B
        • Morris PJ
        Randomized controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression.
        Lancet. 1996; 348: 643-648
        • Grinyo JM
        • Gil-Vernet S
        • Seron D
        • Cruzado JM
        • Moreso F
        • Fulladosa X
        • et al.
        Steroid withdrawal in mycophenolate mofetil-treated renal allograft recipients.
        Transplantation. 1997; 63: 1688-1690